Search Results

There are 945964 results for: content related to: Risk factors for severe anaemia during telaprevir-based triple therapy: is acquired renal dysfunction the missing link?

  1. Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 176–183, Harald Farnik, Tim Zimmermann, Eva Herrmann, Wolf O. Bechstein, Bernd Kronenberger, Peter R. Galle, Sandra Labocha, Nerea Ferreiros, Gerd Geisslinger, Stefan Zeuzem, Christoph Sarrazin and Martin W. Welker

    Version of Record online : 9 APR 2014, DOI: 10.1111/liv.12532

  2. High post-transplant virological response in hepatitis C virus infected patients treated with pretransplant protease inhibitor-based triple therapy

    Liver International

    Volume 35, Issue 2, February 2015, Pages: 510–517, Elizabeth C. Verna, Kirti Shetty, Thresiamma Lukose, Nicole Terry, Kimiknu Mentore, Sonja K. Olsen, Alyson N. Fox, Lorna M. Dove and Robert S. Brown

    Version of Record online : 10 JUL 2014, DOI: 10.1111/liv.12616

  3. Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study

    Liver International

    Volume 35, Issue 2, February 2015, Pages: 448–454, Thomas Berg, Pietro Andreone, Stanislas Pol, Stuart Roberts, Zobair Younossi, Moises Diago, Eric J. Lawitz, Roberto Focaccia, Graham R. Foster, Andrzej Horban, Isabelle Lonjon-Domanec, Ralph DeMasi, Gaston Picchio, Donghan Luo, Sandra De Meyer and Stefan Zeuzem

    Version of Record online : 11 NOV 2014, DOI: 10.1111/liv.12703

  4. Interfering parameters in nonalcoholic fatty liver disease fibrosis score

    Liver International

    Volume 35, Issue 1, January 2015, Page: 285, Erdim Sertoglu, Huseyin Kayadibi and Metin Uyanik

    Version of Record online : 21 AUG 2014, DOI: 10.1111/liv.12650

  5. The use of guideline images to improve histological estimation of hepatic steatosis

    Liver International

    Volume 34, Issue 9, October 2014, Pages: 1414–1427, Andrew R. Hall, Anna C. Green, Tu-Vinh Luong, Andrew K. Burroughs, Judith Wyatt and Amar P. Dhillon

    Version of Record online : 8 JUL 2014, DOI: 10.1111/liv.12614

  6. Laboratory assessment may be dependent on the time of liver biopsy

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 286–287, Huseyin Kayadibi, Erdim Sertoglu and Metin Uyanik

    Version of Record online : 27 AUG 2014, DOI: 10.1111/liv.12654

  7. FibroTest (FT) has similar accuracy for cirrhosis in ‘intention-to-diagnose’ which is superior to transient elastography (TE) in chronic hepatitis B.

    Liver International

    Volume 34, Issue 7, August 2014, Pages: 1128–1129, Mona Munteanu, Marion Houot, Ngo Yen and Thierry Poynard

    Version of Record online : 30 MAY 2014, DOI: 10.1111/liv.12580

  8. Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan

    Liver International

    Volume 35, Issue 5, May 2015, Pages: 1581–1589, Haruhiko Takeda, Hiroki Nishikawa, Yukio Osaki, Kaoru Tsuchiya, Kouji Joko, Chikara Ogawa, Hiroyoshi Taniguchi, Etsuro Orito, Yasushi Uchida, Namiki Izumi and Japanese Red Cross Liver Study Group

    Version of Record online : 9 JUN 2014, DOI: 10.1111/liv.12591

  9. A prospective observational study on tolerance and satisfaction to hepatic haemodynamic procedures

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 695–703, Stefania Casu, Annalisa Berzigotti, Juan G. Abraldes, M. Angels Baringo, Laura Rocabert, Virginia Hernández-Gea, Joan Carles García-Pagán and Jaume Bosch

    Version of Record online : 27 MAR 2014, DOI: 10.1111/liv.12522

  10. TIPS for Budd–Chiari syndrome: time to anticipate treatment

    Liver International

    Volume 34, Issue 7, August 2014, Page: e325, Andrea Mancuso

    Version of Record online : 10 APR 2014, DOI: 10.1111/liv.12544

  11. How Can the IL28B Polymorphisms with Linkage Disequilibrium Affect the Natural Course of Hepatitis B Inversely?

    Liver International

    Volume 34, Issue 7, August 2014, Page: 1127, Maryam Keshvari, Seyed Moayed Alavian and Heidar Sharafi

    Version of Record online : 24 MAR 2014, DOI: 10.1111/liv.12515

  12. Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy

    Liver International

    Volume 34, Issue 7, August 2014, Pages: 1018–1024, James F. Crismale, Valérie Martel-Laferrière, Kian Bichoupan, Emily Schonfeld, Alexis Pappas, Christina Wyatt, Joseph A. Odin, Lawrence U. Liu, Thomas D. Schiano, Ponni V. Perumalswami, Meena Bansal, Douglas T. Dieterich and Andrea D. Branch

    Version of Record online : 25 OCT 2013, DOI: 10.1111/liv.12342

  13. You have free access to this content
    Treatment of chronic hepatitis C virus infection in the United States: some remaining obstacles

    Liver International

    Volume 34, Issue 5, May 2014, Pages: 668–671, Gloria Searson, Ellen S. Engelson, Damaris Carriero and Donald P. Kotler

    Version of Record online : 7 FEB 2014, DOI: 10.1111/liv.12467

  14. You have free access to this content
    A 48-week telaprevir-based triple combination therapy improves sustained virological response rate in previous non-responders to peginterferon and ribavirin with genotype 1b chronic hepatitis C: A multicenter study

    Hepatology Research

    Volume 44, Issue 14, December 2014, Pages: E386–E396, Noritomo Shimada, Akihito Tsubota, Masanori Atsukawa, Hiroshi Abe, Tatsuya Ide, Koichi Takaguchi, Yoshimichi Chuganji, Hidenori Toyoda, Kai Yoshizawa, Makiko Ika, Yoshiyuki Sato, Keizo Kato, Takashi Kumada, Choitsu Sakamoto, Yoshio Aizawa and Michio Sata

    Version of Record online : 15 APR 2014, DOI: 10.1111/hepr.12323

  15. Can we include genetic variants with high linkage disequilibrium into a multiple logistic model? Author's reply

    Liver International

    Volume 34, Issue 6, July 2014, Pages: 965–966, Orazio Palmieri and Maria R. Valvano

    Version of Record online : 28 FEB 2014, DOI: 10.1111/liv.12489

  16. Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting

    Liver International

    Volume 35, Issue 7, July 2015, Pages: 1845–1852, Christoph Höner zu Siederdissen, Benjamin Maasoumy, Katja Deterding, Kerstin Port, Lisa Sollik, Carola Mix, Janina Kirschner, Janet Cornberg, Michael P. Manns, Heiner Wedemeyer and Markus Cornberg

    Version of Record online : 2 FEB 2015, DOI: 10.1111/liv.12774

  17. eGFR decrease during antiviral C therapy with first generation protease inhibitors: a clinical significance?

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 71–78, Véronique Loustaud-Ratti, Annick Rousseau, Paul Carrier, Chanlina Vong, Tristan Chambaraud, Jérémie Jacques, Marilyne Debette-Gratien, Denis Sautereau and Marie Essig

    Version of Record online : 27 JUL 2014, DOI: 10.1111/liv.12631

  18. Response to Dr. Sertoglu and Colleagues

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 285–286, Salvatore Petta, Ester Vanni and Antonio Craxì

    Version of Record online : 25 AUG 2014, DOI: 10.1111/liv.12653

  19. Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study

    Liver International

    Volume 35, Issue 2, February 2015, Pages: 417–421, Stefan Zeuzem, Jean-François Dufour, Maria Buti, Vicente Soriano, Robert J. Buynak, Parvez Mantry, Jawahar Taunk, Jerry O. Stern, Richard Vinisko, John-Paul Gallivan, Wulf Böcher, Federico J. Mensa and on behalf ofthe SOUND-C3 study group

    Version of Record online : 16 OCT 2014, DOI: 10.1111/liv.12693

  20. Synchronous hepatic and splenic inflammatory pseudotumour-like follicular dendritic cell sarcomas

    Liver International

    Volume 35, Issue 7, July 2015, Page: 1917, Ba D. Nguyen, Michael C. Roarke and Ming Yang

    Version of Record online : 15 DEC 2014, DOI: 10.1111/liv.12738